FAQ

Amphotericin B Colloidal Dispersion

Known as: AMPHOTERICIN B CHOLESTERYL SULFATE, Amphotericin B Colloidal Dispersion [Chemical/Ingredient] 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2013
024619922013

Related topics

Related topics

28 relations
AIDS-Related Opportunistic InfectionsAmphotericin 100mg powder for infusion solution vialAmphotericin B 50 MG InjectionAmphotericin B Cholesterol Dispersion
(More)

Broader (3)

Amphotericin BCholesterol Estersamphotericin B liposomal

Related mentions per year

Related mentions per year

1936-2019
19401960198020002020
Amphotericin B Colloidal Dispersion
Drug Allergy
Urinary tract infection
Antifungal Agents
Mycoses
Neutropenia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Amphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasis.
BACKGROUND In Bihar, India, where visceral leishmaniasis (VL) is hyperendemic and refractory to antimony, amphotericin B is the… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.
We conducted a prospective, randomized, double-blind study comparing amphotericin B colloidal dispersion (ABCD) with amphotericin… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
1998
1998
Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis.
Studies with animals and in vitro studies have demonstrated that flucytosine plus amphotericin B or fluconazole has significantly… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
1997
1997
Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis.
To assess the efficacy and safety of amphotericin B colloidal dispersion (ABCD), 82 patients with proven or probable… (More)
Is this relevant?
1997
1997
Safety of amphotericin B colloidal dispersion
The safety of amphotericin B colloidal dispersion (ABCD) was tested in five open-label Phase I/II clinical trials in 572 selected… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
1997
1997
Sequential treatment of deep fungal infections with amphotericin B deoxycholate and amphotericin B colloidal dispersion
Amphotericin B colloidal dispersion (ABCD) is a novel lipid formulation of amphotericin B designed to diminish toxic effects of… (More)
  • table 1
  • table 2
Is this relevant?
1995
1995
The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses.
Amphotericin B colloidal dispersion (ABCD), a novel formulation of amphotericin B and cholesteryl sulfate in a 1:1 ratio, was… (More)
Is this relevant?
1995
1995
Comparative Tissue Distribution and Elimination of Amphotericin B Colloidal Dispersion (Amphocil®) and Fungizone® After Repeated Dosing in Rats
The pharmacokinetic profiles of amphotericin B (AmB) after administration of Amphocil®, an AmB/cholesteryl sulfate colloidal… (More)
Is this relevant?
1994
1994
Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis.
We investigated the safety and efficacy of amphotericin B colloidal dispersion (ABCD) for the treatment of invasive pulmonary… (More)
Is this relevant?
1992
1992
Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis.
The efficacy and safety of amphotericin B colloidal dispersion (ABCD) were compared with those of amphotericin B deoxycholate… (More)
Is this relevant?